Dan G. Duda, DMD, PhD
Harvard University
H-index: 90
North America-United States
Top articles of Dan G. Duda, DMD, PhD
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective Against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy | bioRxiv | Bocheng Wu Subhasish Tapadar Zhiping Ruan Carrie Sun Rebecca Arnold | 2024 |
The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic … | Radiotherapy and Oncology | Philip J Saylor Sergey V Kozin Aya Matsui Saveli I Goldberg Shuichi Aoki | 2024/3/1 |
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer | medRxiv | Prashant Dogra Vrushaly Shinglot Javier Ruiz Ramirez Joseph Cave Joseph D Butner | 2024 |
Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti–PD-1 Therapy | Cancer Immunology Research | Jiang Chen Zohreh Amoozgar Xin Liu Shuichi Aoki Zelong Liu | 2024/2/20 |
Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma | Journal of Hepatocellular Carcinoma | Shadi Chamseddine Michael LaPelusa Lianchun Xiao Yehia I Mohamed Sunyoung S Lee | 2024/12/31 |
A Chemoimmunotherapy Nanogel Enables Efficient Delivery of Interleukin‐2 and Induction of Immunogenic Cell Death for Effective Cancer Therapy | Advanced Functional Materials | Hsuan‐Yu Mu Yen‐Nhi Ngoc Ta Max Jing Rui Tham Fu‐Fei Hsu Yu‐Chieh Lin | 2024/1 |
SWOG S2303: Randomized phase II/III trial of 2nd line nivolumab+ paclitaxel+ ramucirumab versus paclitaxel+ ramucirumab in patients with PD-L1 CPS≥ 1 advanced gastric and … | Anwaar Saeed Sarah Colby Paul Eliezer Oberstein Dan G Duda Rajiv Agarwal | 2024/1/20 | |
Scirrhous HCC: Another ‘omic thread in the HCC tapestry | Joseph W Franses Dan G Duda | 2024/4/1 | |
Serologic, radiographic, and tissue-based markers associated with major pathologic response after treatment with neoadjuvant immunotherapy in patients with resectable … | Michael Brian LaPelusa Shadi Chamseddine Lianchun Xiao Elshad Hasanov Priya Bhosale | 2024/1/20 | |
Enhancing cancer treatment Via a nanostructured chemoimmunotherapy gel facilitating interleukin-2 delivery and immunogenic cell death induction | Cancer Research | Hsuan Yu Mu Yen-Nhi Ngoc Ta Jing Rui Max Tham Fu-Fei Hsu Yu-Chieh Lin | 2024/3/22 |
Abstract B025: IL-1 blockade prevents cardiac toxicity and improves immunotherapy efficacy in mouse models of pancreatic cancer | Cancer Research | Nilesh P Talele Heena Kumra Igor L Gomes-Santos Sylvie Roberge William W Ho | 2024/1/16 |
Abstract PR-004: Targeting EPHB2/ABL1 restores anti-tumor immunity in a preclinical model of ependymoma | Cancer Research | Taylor P Uccello Jun Ren Zohreh Amoozgar Yuhui Zhao Pin-Ji Lei | 2024/3/4 |
A tumor microenvironment-based classification of gastric cancer for more effective diagnosis and treatment | Research Square | Dan Duda Simona Dima Andrei Sorop Shuji Kitahara Namrata Setia | 2023/8/1 |
Soluble PD-L1 as a diagnostic and prognostic biomarker in resectable gastric cancer patients | Gastric Cancer | Mihaela Chivu-Economescu Vlad Herlea Simona Dima Andrei Sorop Catalin Pechianu | 2023/11 |
Combined blockade of CXCR4 and PD-1 enhances intratumoral dendritic cell activation and immune responses against HCC | bioRxiv | Satoru Morita Kohei Shigeta Pinji Lei Tatsuya Kobayashi Hiroto Kikuchi | 2023 |
Targeting EPHB2/ABL1 restores anti-tumor immunity in a preclinical model of ependymoma | Cancer Research | Jun Ren Zohreh Amoozgar Yuhui Zhao Pinji Lei William W Ho | 2023/4/4 |
Predictive Model of Liver Toxicity to Aid the Personalized Selection of Proton Versus Photon Therapy in Hepatocellular Carcinoma | International Journal of Radiation Oncology* Biology* Physics | Ibrahim Chamseddine Yejin Kim Brian De Issam El Naqa Dan G Duda | 2023/8/1 |
Preventing NK cell activation in the damaged liver induced by cabozantinib/PD-1 blockade increases survival in hepatocellular carcinoma models | bioRxiv | Satoru Morita Hiroto Kikuchi Grace Birch Aya Matsui Atsuyo Morita | 2023/10/23 |
Refining genetic and molecular classifications to facilitate breakthrough treatments in intrahepatic cholangiocarcinoma: are we there yet? | Satoru Morita Dan G Duda | 2023/4/1 | |
Predicting severity of radiation induced lymphopenia in individual proton therapy patients for varying dose rate and fractionation using dynamic 4-dimensional blood flow … | International Journal of Radiation Oncology* Biology* Physics | Lucas McCullum Jungwook Shin Stella Xing Chris Beekman Jan Schuemann | 2023/8/1 |
